Read more about the recent developments in the life sciences sector.
Content :
- Antitrust: The Servier Case: The Game isn’t Over Yet
- Corportate Finance: Overview of financing options for French biotech companies
- Regulatory: Health is priceless; supply shortages come at a high price, as determined by the sanctions imposed by the French Health Agency.
- Antitrust: Illumina/Grail: EU Court overturns approach to “killer acquisitions”
- Regulatory: Healthcare Center Investor Saga: French Court Rules on Minority Shareholding by Non-Healthcare Professionals
Related Professionals
Related Services
